Netherlands· NL-ed2452ead89b
Giapreza 2,5 mg/ml concentraat voor oplossing voor infusie
A angiotensin ii product containing angiotensine ii acetaat, registered in Netherlands by Paion Pharma GmbH. The same ATC class is registered in 11 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Angiotensin ii is registered in 11 of 19 countries.
Countries holding a registration under ATC C01CX09 (angiotensin ii), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 7 of them publish a price we can compare per daily dose
Angiotensin ii · ATC C01CX09
11 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- United Kingdom
- United Statesprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- ANGIOTENSINE II ACETAAT
- Manufacturer
- Paion Pharma GmbH
- Country
- Netherlands (NL)
- ATC code
- C01CX09
- ATC class
- Angiotensin II
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_idEU/1/19/1384
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Angiotensin ii in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FranceGIAPREZA 2,5 mg/ml, solution à diluer pour perfusionPAION PHARMA (ALLEMAGNE)
- United StatesANGIOTENSIN IIGland Pharma Limited
- United KingdomGiapreza 2.5mg/1ml concentrate for solution for infusion vialsPAION Pharma GmbH
- SpainGIAPREZA 2,5 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSIONPaion Pharma Gmbh
- NorwayGiaprezaPAION Pharma GmbH
- SwedenGIAPREZA 2,5 mg/ml Koncentrat till infusionsvätska, lösningPAION Pharma GmbH
- IcelandGiaprezaPAION Pharma GmbH
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Giapreza
- Liechtenstein · Giapreza
- Norway · Giapreza
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/7da6e3de-933a-45a0-9a8d-5820af30a8e7 GET /v1/drugs/7da6e3de-933a-45a0-9a8d-5820af30a8e7?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Concentraat voor oplossing voor infusie",
"route": "Intraveneus gebruik",
"soort": null,
"source": "cbg_meb",
"smpc_url": "https://www.ema.europa.eu/en/documents/product-information/giapreza-epar-product-information_nl.pdf",
"strength": null,
"atc_label": "Angiotensin II",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp123289",
"excipients": [
"MANNITOL (D-) (E 421)",
"NATRIUMHYDROXIDE (E 524)",
"WATER VOOR INJECTIE",
"ZOUTZUUR (E 507)"
],
"substances": [
"ANGIOTENSINE II ACETAAT"
],
"leaflet_url": null,
"authorised_at": "2019/08/23",
"procedure_number": "EMEA/H/C/004930",
"dispensing_status": "Uitsluitend recept",
"registration_number": "EU/1/19/1384",
"additional_monitoring": "Y"
}See everything about angiotensin ii.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.